Health TrialsbyHealthPanel

Real-life Performance Evaluation of the LiFlow X-ray Platform

ConditionSolid Cancers
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Angers

About this trial

The thoraco-abdomino-pelvic (TAP) scanner is crucial for assessing and monitoring solid cancers. However, advancements in scanner technology have led to a significant increase in data volume, from 100 images per exam 20 years ago to 2,000 today. The rising number of cancer cases and treatments requiring closer monitoring further strain the workload, prolonging interpretation time and causing delays in therapeutic management and adjustments. The limited number of radiologists contributes to this saturation, increasing the risk of missing metastatic lesions, especially in the lungs, liver, bones, peritoneum, and lymph nodes. The RECIST 1.1 criteria, introduced 15 years ago for standardized follow-up, are useful but time-consuming to implement, resulting in only a small fraction of oncology CT reports using them.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

TAP (thoraco-abdomino-pelvic) scans

Age > 18 years

Disqualifiers

Examination of imperfect quality due to movement or breathing,

Inability to inject contrast medium or incomplete injection

refusal to use data

Trial population

patients treated for solid cancer

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Radiologist interpretation

    Other intervention

    two interpretations (with and without Liflow, oncology imaging tool).

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Time elapsed between opening and closing, oncology interpretation completed, of the same file interpreted

Time frame
1 day

Secondary outcomes

1

Number of additional relevant lesions discovered

Time frame
Day 1
2

Duration recorded for examinations with no relevant lesions and pathological examinations

Time frame
Day 1
3

Recorded times for initial and follow-up examinations

Time frame
Day 1
4

Location and size of lesion(s) on report and nature of primary tumor in patient file

Time frame
Day 1

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Angers

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: